New Publication Shows Surprisingly Positive Results With Oncolytic Virus Rigvir
New Publication Shows Surprisingly Positive Results With Oncolytic Virus Rigvir
Press Release – Aug 8, 2016 Riga, Latvia, August 8, 2016 (Newswire.com) – The surprisingly positive treatment outcomes using Rigvir virotherapy for late stages cancer patients were recently published. The patients of melanoma stage IV M1c, small cell lung cancer stage IIIA and histiocytic sarcoma stage IV started virotherapy with Rigvir within a few months after being diagnosed and are…
View On WordPress














